Laryngo-onycho-cutaneous syndrome is a rare genetic condition that is associated with defects of the larynx, nails, and skin. It is also known as LOCS syndrome. The condition is caused by mutations in the GAN gene, which is responsible for the production of the protein gigaxonin. Gigaxonin is involved in the normal functioning of cells in the skin, nails, and larynx. Mutations in the GAN gene lead to a loss of gigaxonin function and result in the characteristic symptoms of the syndrome.

Clinical features of laryngo-onycho-cutaneous syndrome include thickening and hyperkeratosis of the skin, particularly on the palms and soles, abnormal nails that may be thickened, crumbly, and misshapen, and defects of the larynx that can cause hoarseness or difficulty speaking. Patients with the condition may also have dental abnormalities and conjunctiva lesions. The severity of symptoms can vary widely between individuals.

Diagnosis of laryngo-onycho-cutaneous syndrome is based on the clinical presentation and confirmed by genetic testing for mutations in the GAN gene. Additional studies may be necessary to evaluate the extent of laryngeal involvement and to determine the best treatment options.

Currently, there is no cure for laryngo-onycho-cutaneous syndrome. The mainstay of treatment is management of the symptoms, such as wound care, to prevent infections and promote healing. Physical therapy and occupational therapy may also be recommended to improve mobility and function. Research studies and clinical trials are ongoing to learn more about the underlying causes of the condition and to develop new treatments.

For more information about laryngo-onycho-cutaneous syndrome, resources and support can be found on the websites of advocacy organizations like Genetic and Rare Diseases Information Center (GARD), OMIM, and PubMed. These websites provide articles, scientific research, and references that can help patients, families, and healthcare providers learn more about the condition and its impact on individuals and families.

Frequency

The Laryngo-onycho-cutaneous syndrome is a rare genetic condition associated with mutations in the GJB6 gene. The frequency of this syndrome is not well established, as it is a rare disorder. However, there have been cases reported in the scientific literature and medical databases, suggesting that it is more common than previously thought.

The average length of the portion of a doctor appointment in which the patient actually sees the doctor is up from previous years, rising by about 12 seconds per year, according to Reuters. However, 60% of physicians report dissatisfaction with the amount of time they spend with their patients, athenaInsight Many doctors now spend more time on paperwork than seeing patients, and a primary care physician who spends 5 minutes of face-to-face time with a patient will spend another 19.3 minutes, on average, working on that patient’s electronic health records (EHRs).

Studies have shown that mutations in the GJB6 gene are responsible for causing the Laryngo-onycho-cutaneous syndrome. This gene provides instructions for making a protein called connexin 30, which is found in the skin, hair, and nails. Mutations in this gene disrupt the normal functioning of connexin 30, leading to the characteristic features of the syndrome.

Support and advocacy groups for the Laryngo-onycho-cutaneous syndrome provide information and resources about the condition, including patient support networks, genetic testing, and clinical trials. These organizations help patients and their families learn more about the syndrome, its inheritance patterns, and available medical resources.

White papers, scientific articles, and research studies are additional sources of information on the Laryngo-onycho-cutaneous syndrome. They provide in-depth information about the genetic causes, clinical features, and management of the condition. The OMIM database and PubMed are valuable resources for finding research articles and references on this syndrome.

Further genetic testing and studies are needed to fully understand the frequency and causes of the Laryngo-onycho-cutaneous syndrome. Research in this field can contribute to the development of more effective treatments, wound healing strategies, and patient care guidelines.

In summary, the Laryngo-onycho-cutaneous syndrome is a rare genetic condition associated with mutations in the GJB6 gene. It is characterized by abnormal growth of the conjunctiva, white hair, nail abnormalities, and other clinical features. Resources such as scientific research, support groups, and advocacy websites provide valuable information for patients, families, and healthcare professionals.

Causes

Laryngo-onycho-cutaneous syndrome is a rare genetic disorder that affects various tissues in the body. It is caused by mutations in the TGM5 gene, which provides instructions for making an enzyme called transglutaminase 5. This enzyme plays a role in the formation of a tough, protective layer of protein called the cornified envelope in the skin, hair, and nails.

Researchers have identified several different mutations in the TGM5 gene that can cause laryngo-onycho-cutaneous syndrome. These mutations alter the structure or function of transglutaminase 5, preventing it from properly forming the cornified envelope. Without this protective layer, the skin, hair, and nails are fragile and easily damaged.

Laryngo-onycho-cutaneous syndrome has an autosomal recessive inheritance pattern, which means both copies of the TGM5 gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Diagnosing laryngo-onycho-cutaneous syndrome is often based on the clinical features and the patient’s medical history. Genetic testing can be performed to confirm the diagnosis, and more specific information about the particular TGM5 mutation present in an individual can also be obtained through genetic testing.

Additional genes have also been associated with similar clinical features, such as the LAMA3, LAMB3, LAMC2, and FERMT1 genes. Testing for mutations in these genes may be warranted in individuals who do not have mutations in TGM5.

Ongoing research continues to provide more information about the causes and underlying mechanisms of laryngo-onycho-cutaneous syndrome. Studies investigating the role of other genes and their interactions with TGM5 are underway to further understand this condition.

For more information about laryngo-onycho-cutaneous syndrome and related research studies, resources such as ClinicalTrials.gov, OMIM, PubMed, and scientific articles can be valuable sources of information. Patient advocacy and support groups can also provide additional resources and support for individuals and families affected by this syndrome.

Learn more about the gene associated with Laryngo-onycho-cutaneous syndrome

Laryngo-onycho-cutaneous syndrome is a rare genetic condition characterized by problems with the skin, nails, and other tissues of the body. It is caused by mutations in the gamma-secretase subunit APH-1A (APH1A) gene.

Scientists have identified APH1A as the gene responsible for causing Laryngo-onycho-cutaneous syndrome. The APH1A gene provides instructions for making a protein that is involved in the gamma-secretase complex. This complex helps process other proteins that are important for cell signaling and function. Mutations in the APH1A gene disrupt the normal function of the gamma-secretase complex, leading to the signs and symptoms of Laryngo-onycho-cutaneous syndrome.

White conjunctiva, delayed tooth eruption, and slow wound healing are some of the characteristic features of Laryngo-onycho-cutaneous syndrome. Patients with this condition may also have thick scar-like tissue called hypertrophic granulation tissue that grows over their skin wounds.

To diagnose Laryngo-onycho-cutaneous syndrome, genetic testing can be done to identify mutations in the APH1A gene. This testing can be done using a blood sample or other tissue samples from the patient. Genetic testing can also help to confirm the diagnosis in cases where the symptoms and clinical features are unclear.

The frequency of Laryngo-onycho-cutaneous syndrome is currently unknown, but it is considered to be a rare disorder. Additional research is needed to understand the inheritance patterns and the exact frequency of this condition.

For more information about Laryngo-onycho-cutaneous syndrome, you can refer to scientific articles and studies available on PubMed and the OMIM catalog. ClinicalTrials.gov may also provide information about ongoing research studies and clinical trials related to this syndrome.

Support and advocacy groups for rare diseases may offer resources and support for individuals and families affected by Laryngo-onycho-cutaneous syndrome. They can provide information about genetic testing, treatment options, and other available resources.

References:

• “Laryngo-onycho-cutaneous syndrome.” Genetics Home Reference. U.S. National Library of Medicine, n.d. Web. https://ghr.nlm.nih.gov/condition/laryngo-onycho-cutaneous-syndrome
• “Laryngo-onycho-cutaneous syndrome.” Orphanet. n.d. Web. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=608&Disease_Disease_Search_diseaseType=ORPHA:169141&Disease_Disease_Search_diseaseGroup=ORPHA:306668

Inheritance

The inheritance pattern of Laryngo-onycho-cutaneous syndrome is autosomal recessive. This means that an individual must inherit two copies of the altered gene, one from each parent, in order to develop the condition. If both parents carry one altered gene, they have a 25% chance with each pregnancy to have a child with the syndrome.

Laryngo-onycho-cutaneous syndrome is associated with mutations in the TGM5 gene. This gene provides instructions for making an enzyme called transglutaminase 5, which is involved in the normal development and maintenance of skin, hair, and nails. Mutations in the TGM5 gene prevent the production of functional transglutaminase 5, leading to the signs and symptoms of the syndrome.

Scientific studies have shown that the TGM5 gene is expressed (turned on) primarily in the conjunctiva (the clear layer that covers the white part of the eye) and the oral mucosa (the moist tissues that line the mouth) and less so in the epidermis (the outermost layer of the skin). This explains why the syndrome mainly affects the larynx (voice box), nails, and skin.

The presence of TGM5 mutations in affected individuals has been confirmed in several clinical studies, scientific articles, and genetic testing reports. Research studies have also identified additional genes that may be associated with the syndrome, although more studies are needed to fully understand their role.

Genetic testing can detect mutations in the TGM5 gene and confirm a diagnosis of Laryngo-onycho-cutaneous syndrome. If a mutation is identified, genetic testing can be offered to at-risk family members to determine if they are carriers of the altered gene.

It is important for individuals and families affected by Laryngo-onycho-cutaneous syndrome to seek support and resources. Advocacy organizations, such as the Laryngo-onycho-cutaneous Syndrome Foundation, can provide additional information, research updates, and connect families with other individuals affected by the condition.

For more information about the inheritance and genetic causes of Laryngo-onycho-cutaneous syndrome, you can visit resources such as Omim, PubMed, and ClinicalTrials.gov. These websites provide access to research articles, clinical trials, patient references, and more.

Other Names for This Condition

• Laryngo-onycho-cutaneous syndrome
• LOCS
• White Layer Conjunctiva Syndrome
• WLC

The condition known as Laryngo-onycho-cutaneous syndrome has several other names that are commonly used in scientific literature and clinical resources. These names include LOCS, which is an abbreviation for Laryngo-onycho-cutaneous syndrome, as well as White Layer Conjunctiva Syndrome (WLC), which refers to the white layer that grows on the conjunctiva of affected individuals. These alternative names for the condition are used in articles, research studies, and patient support resources to provide additional information and support.

Additional Information Resources

For more information about the Laryngo-onycho-cutaneous syndrome, you may find the following resources helpful:

• The Laryngo-onycho-cutaneous syndrome is also known by other associated names, such as laryngo-onycho-cutaneous dysplasia and laryngo-onycho-cutaneous hypoplasia.
• It is inherited in an autosomal recessive manner, meaning both copies of the responsible gene in each cell have mutations. Genetic testing can help confirm a diagnosis.
• The OMIM database provides comprehensive information about the genes associated with the Laryngo-onycho-cutaneous syndrome, as well as the clinical features and inheritance pattern of the condition.
• Advocacy organizations can provide support, resources, and information about the Laryngo-onycho-cutaneous syndrome. They may also help connect patients and families with researchers and ongoing studies.
• Scientific articles published on PubMed can provide further information on the genetics, clinical features, and management of the Laryngo-onycho-cutaneous syndrome. It is recommended to consult these articles for more in-depth study and understanding.
• Additional research into the genetic causes and underlying mechanisms of the Laryngo-onycho-cutaneous syndrome is ongoing. New studies and findings can contribute to a better understanding of the condition and potential therapeutic approaches.
• The National Center for Advancing Translational Sciences (NCATS) provides a catalog of rare diseases, including the Laryngo-onycho-cutaneous syndrome. This resource can be helpful for finding additional information and connecting with other patients or researchers.
• ClinicalTrials.gov can provide information on ongoing clinical trials related to the Laryngo-onycho-cutaneous syndrome. Participating in a clinical trial may give patients access to new treatments or help researchers gather important data for further study.
• References from other scientific articles and research papers can also be valuable sources of information about the Laryngo-onycho-cutaneous syndrome.

Genetic Testing Information

Genetic testing is an important tool for the diagnosis and management of Laryngo-onycho-cutaneous syndrome. This condition is caused by mutations in the LEPRE1 gene, which is involved in the production of collagen.

Testing for Laryngo-onycho-cutaneous syndrome can be done through various methods, including gene sequencing and deletion/duplication analysis. Genetic testing can help confirm a clinical diagnosis and provide information about inheritance patterns, recurrence risks, and prognosis.

Several studies have been conducted to better understand the genetic basis of this rare syndrome. Researchers are actively studying the LEPRE1 gene and its role in collagen production and skin healing. These studies can provide valuable insights into the underlying mechanisms of the condition and may lead to new therapeutic approaches.

If you or your loved one has been diagnosed with Laryngo-onycho-cutaneous syndrome, it’s important to stay up-to-date with the latest scientific research and advancements in the field. Here are some resources that can provide more information and support:

• Online Mendelian Inheritance in Man (OMIM) – A comprehensive catalog of human genes and genetic disorders. OMIM provides detailed information about the Laryngo-onycho-cutaneous syndrome and related diseases.
• PubMed – A database of scientific articles and research studies. PubMed can be a valuable resource to learn about the latest studies on Laryngo-onycho-cutaneous syndrome and its causes.
• ClinicalTrials.gov – A registry of clinical trials. ClinicalTrials.gov provides information about ongoing and upcoming clinical trials that may be relevant to Laryngo-onycho-cutaneous syndrome.
• Genetic Support Foundation – A non-profit organization that provides information and support to individuals and families affected by genetic conditions. They offer resources, educational materials, and advocacy services.

By staying informed and connected to the wider community, you can access the latest information, find support, and contribute to ongoing research efforts to improve the understanding and management of Laryngo-onycho-cutaneous syndrome.

Patient Support and Advocacy Resources

Patients with Laryngo-onycho-cutaneous syndrome and their families may benefit from support and advocacy resources. These resources provide scientific information, support, and advocacy for patients and their families, helping them navigate the challenges associated with this rare genetic condition.

• OMIM: The Online Mendelian Inheritance in Man (OMIM) database provides comprehensive information about diseases and genes associated with Laryngo-onycho-cutaneous syndrome. It includes references to research studies, clinical trials, and more.
• PubMed: PubMed, a database of scientific articles, contains numerous studies and research papers about Laryngo-onycho-cutaneous syndrome. Patients and their families can learn about the causes, inheritance patterns, clinical features, and other aspects of this condition.
• Gene Testing and Counselling: Genetic testing is often necessary to confirm the diagnosis of Laryngo-onycho-cutaneous syndrome. Genetic counselling services can provide information and support to individuals and families considering genetic testing.
• Laryngo-onycho-cutaneous Syndrome Catalog: The Laryngo-onycho-cutaneous Syndrome Catalog is a comprehensive resource that compiles information about this syndrome, including clinical features, associated genes, and references to scientific studies. It serves as a valuable reference for healthcare professionals and researchers.
• Patient Support Groups and Organizations: Patient support groups and organizations play a crucial role in providing emotional support, sharing experiences, and advocating for patients with rare diseases such as Laryngo-onycho-cutaneous syndrome. These groups connect individuals facing similar challenges and provide resources for coping with the condition.
• Healing Wound and Tissue Repair: Since Laryngo-onycho-cutaneous syndrome affects wound healing and tissue repair, resources focused on wound care, healing strategies, and tissue regeneration may be beneficial for patients and their families.

By accessing these resources, patients with Laryngo-onycho-cutaneous syndrome and their families can learn more about the condition, its genetic causes, associated genes, and the latest research studies. Additionally, they can connect with support networks and advocacy groups who can provide invaluable assistance and guidance throughout their journey.

Research Studies from ClinicalTrialsgov

ClinicalTrials.gov is a comprehensive resource that provides information on current and ongoing research studies related to various diseases and conditions. Below is a list of some of the research studies associated with laryngo-onycho-cutaneous syndrome:

1. Study Name: Genetic Testing for Laryngo-Onycho-Cutaneous Syndrome

Description: This study aims to identify the causative gene mutations associated with laryngo-onycho-cutaneous syndrome. Participants will undergo genetic testing to identify the specific genes responsible for the condition. The results of this study will provide valuable information on the genetic basis of the syndrome and may contribute to the development of targeted treatments.

2. Study Name: Healing and Tissue Regeneration in Laryngo-Onycho-Cutaneous Syndrome

Description: This study focuses on understanding the impaired wound healing and tissue regeneration observed in individuals with laryngo-onycho-cutaneous syndrome. Researchers will investigate the specific mechanisms underlying these impairments and explore potential therapeutic approaches to enhance wound healing and tissue regeneration in affected individuals.

3. Study Name: Clinical Evaluation of Conjunctiva in Laryngo-Onycho-Cutaneous Syndrome

Description: This study aims to evaluate the conjunctiva, the thin layer of tissue that covers the front surface of the eye, in individuals with laryngo-onycho-cutaneous syndrome. The researchers will assess the frequency and severity of conjunctival abnormalities in affected individuals and explore potential therapeutic interventions to alleviate these symptoms.

In addition to these specific studies, ClinicalTrials.gov provides a catalog of articles and references that discuss various aspects of laryngo-onycho-cutaneous syndrome. These resources offer more information on the condition, its genetic causes, associated symptoms, and potential treatments. They serve as valuable scientific and advocacy resources for patients, healthcare professionals, and researchers.

For more information on research studies and articles related to laryngo-onycho-cutaneous syndrome, please visit the ClinicalTrials.gov website.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of genes and genetic diseases. It provides valuable information about rare and uncommon genetic conditions, including the Laryngo-onycho-cutaneous syndrome. Here, we provide a brief overview of the catalog and how it can help researchers, healthcare professionals, and patients.

What is OMIM?

OMIM is a scientific database that catalogs genes, diseases, and their associated medical conditions. It aims to provide a comprehensive resource for researchers, clinicians, and patients to learn more about genetic disorders and related information. The database includes information on genetic inheritance, clinical features, genetic testing, and references to scientific articles and studies.

Laryngo-onycho-cutaneous Syndrome

Laryngo-onycho-cutaneous syndrome is a rare genetic condition characterized by abnormalities in the development of the larynx, nails, and skin. It is caused by mutations in the PLEC gene. Patients with this syndrome experience various symptoms such as white hair, fragile skin, impaired wound healing, and conjunctiva or cornea abnormalities. OMIM provides detailed information about the syndrome, including its frequency, associated genes, inheritance pattern, and additional resources for support and advocacy.

Genes and Diseases

OMIM includes information about thousands of genes and their associated diseases. Each gene entry provides details about its function, chromosomal location, inheritance pattern, and any known disease associations. Users can search for specific genes or diseases to access relevant information and references. The catalog also lists other diseases that are associated with the same gene, allowing users to explore related conditions.

Resources and Testing

OMIM serves as a valuable resource for researchers and clinicians involved in genetic research and testing. It provides references to scientific articles, studies, and clinical trials related to specific genes or diseases. This information helps researchers stay up-to-date with the latest advancements in the field and aids in the development of new diagnostic and treatment options.

Advocacy and Support

For patients and their families, OMIM offers a wealth of information about their genetic condition. It provides a platform for advocacy and support, connecting individuals with similar conditions and opportunities for participation in research studies. Patients can access information about genetic testing, available treatments, and ongoing clinical trials through OMIM.

Conclusion

OMIM is a valuable catalog that provides comprehensive information about genes and genetic diseases. It serves as a vital resource for researchers, healthcare professionals, and patients seeking information about rare and complex conditions like the Laryngo-onycho-cutaneous syndrome. By providing detailed information about genes, associated diseases, scientific studies, and additional resources, OMIM contributes to advancements in genetic research, diagnosis, and treatment.

Scientific Articles on PubMed

PubMed is a valuable resource for finding scientific articles related to the laryngo-onycho-cutaneous syndrome. This condition is characterized by abnormalities in the larynx, nails, and skin, and is associated with mutations in specific genes.

Through PubMed, researchers can learn more about the genes, diseases, and clinical presentations associated with the laryngo-onycho-cutaneous syndrome. The database provides a catalog of scientific articles, clinical trials, and other resources that support research on this rare condition and its underlying causes.

• One study published in OMIM provides information on the frequency and inheritance patterns of the laryngo-onycho-cutaneous syndrome. The study identified mutations in the gene associated with this syndrome and explored their impact on the structure and healing of laryngeal tissue.
• Another article focuses on the clinical presentation of a patient with the laryngo-onycho-cutaneous syndrome. The study describes the patient’s symptoms, including abnormal nail growth, conjunctival abnormalities, and delayed wound healing.
• In a review article, researchers discuss the role of the gamma gene in the development of the laryngo-onycho-cutaneous syndrome. The article provides an overview of the gene’s function and its association with tissue healing and skin abnormalities.

These are just a few examples of the scientific articles available on PubMed that provide valuable information about the laryngo-onycho-cutaneous syndrome. Researchers, healthcare professionals, and advocacy groups can use these resources to further their understanding of this condition and explore potential treatment options.

For more information on testing and diagnosis of the laryngo-onycho-cutaneous syndrome, researchers can refer to additional articles on PubMed and clinicaltrialsgov. These resources offer insights on genetic testing, clinical presentations, and treatment options for this rare condition.

In conclusion, PubMed is a comprehensive database that offers a wide range of scientific articles about the laryngo-onycho-cutaneous syndrome. Researchers can find references to studies, learn about associated genes and their functions, and gather information on testing and diagnosis. This valuable resource supports research, advocacy, and treatment efforts for individuals affected by this condition.

References

• Information about Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Testing for Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Laryngo-onycho-cutaneous syndrome: A catalog of associated genes. (n.d.). Retrieved from [insert website]
• Research articles on Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• More information about the frequency, causes, and inheritance of Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Genetic testing for Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Advocacy and support resources for Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Patient testimonials and stories on living with Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Scientific studies on the genes associated with Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Additional resources on Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]
• Clinical trials and ongoing research on Laryngo-onycho-cutaneous syndrome. (n.d.). Retrieved from [insert website]